Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Gilead sciences, inc. crawled time : 06:00 save search
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
Published: 2024-01-02 (Crawled : 06:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.12%
H: 3.52%
C: 2.88%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -0.12%
H: 2.22%
C: 1.82%
jyseleca transfer business agreement
New Biktarvy® Data Presented at IAS 2023 Further Demonstrate Safety and Efficacy Profile in a Broad Range of People and Communities Affected by the Global HIV Epidemic
Published: 2023-07-24 (Crawled : 06:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.02%
H: 0.45%
C: -2.71%
biktarvy global hiv
Gilead Announces Clinical Hold on Studies Evaluating Injectable Lenacapavir for HIV Treatment and Prevention Due to Vial Quality Concerns
Published: 2021-12-22 (Crawled : 06:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.35%
H: 1.22%
C: 1.17%
clinical hold treatment hiv
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
Published: 2021-10-04 (Crawled : 06:00) - globenewswire.com
GLPGF | News | $35.5157 71.75% 4.8K
|
Health Technology
|
| O: -4.52%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.09%
H: 1.21%
C: -0.94%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -1.82%
H: 0.04%
C: -1.29%
disease phase 3 enroll
NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir
Published: 2021-04-06 (Crawled : 06:00) - prnewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.51%
H: 0.77%
C: 0.35%
trial aviptadil
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
NYC 4 | $5.91 -4.83% 14.38% 770
|
Finance
MGOL 4 | $0.229 -4.18% 13.72% 420K
|
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K
|
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K
|
MGLD 4 | $1.23 8.85% 7.32% 14K
|
Manufacturing
GRFX | $0.2116 -1.58% 7.28% 40K
|
n/a
LYT | $4.22 4.72% 5.62% 1.4M
|
SYY | $76.73 1.44% 5.49% 2.5M
|
Distribution Services
Your saved searches
Save your searches and get alerts when important news are released.